HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"count": 434,
"next": "http://api.gregory-ms.com/trials/source/12/?page=2",
"previous": null,
"results": [
{
"title": "Kinesiotape on Balance in With Multiple Sclerosis",
"summary": "<b>Conditions</b>: Individuals With Multiple Sclerosis; With Ataxia Symptoms; No Secondary Disease Affecting Balance<br /><b>Intervention</b>: Other: Kinesiotape<br /><b>Sponsor</b>: Firat University<br /><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05341895?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2022-04-22T16:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2022-04-22T12:30:07.386002Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "Functional Outcomes From Diets in Multiple Sclerosis",
"summary": "<b>Conditions</b>: Relapsing Remitting Multiple Sclerosis; Secondary Progressive Multiple Sclerosis<br /><b>Interventions</b>: Behavioral: Glycemic load; Behavioral: Calorie restriction; Behavioral: Behavioral support<br /><b>Sponsors</b>: University of Alabama at Birmingham; Washington University School of Medicine; United States Department of Defense<br /><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05327322?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2022-04-14T16:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2022-04-14T10:59:17.162522Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis",
"summary": "<b>Conditions</b>: Multiple Sclerosis, Relapsing-Remitting; Adult ALL; Vitamin D3 Deficiency<br /><b>Interventions</b>: Dietary Supplement: 25(OH)D3; Dietary Supplement: vitamin D3<br /><b>Sponsors</b>: Tehran University of Medical Sciences; Boston University<br /><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05340985?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2022-04-22T16:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2022-04-22T12:30:07.387904Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years",
"summary": "<b>Condition</b>: Relapsing Multiple Sclerosis<br /><b>Intervention</b>: Other: Ofatumumab<br /><b>Sponsor</b>: Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05776888?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2023-03-20T12:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2023-03-20T17:40:48.910361Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": [
{
"category_id": 39,
"category_description": "ofatumumab, Kesimpta",
"category_name": "ofatumumab",
"category_slug": "ofatumumab",
"category_terms": [
"ofatumumab",
"kesimpta"
]
}
]
},
{
"title": "Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration",
"summary": "<b>Conditions</b>: Multiple Sclerosis; Primary Progressive Multiple Sclerosis; Secondary-progressive Multiple Sclerosis<br /><b>Interventions</b>: Drug: Metformin Hydrochloride 850 mg Oral Tablet; Drug: Placebo<br /><b>Sponsors</b>: University Hospital, Antwerp; University Hospital, Ghent; Hasselt University; AZ Sint-Jan AV; Noorderhart Pelt; National MS Center Melsbroek<br /><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05893225?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2023-06-07T16:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2023-06-07T12:50:42.279113Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": [
{
"category_id": 6,
"category_description": "",
"category_name": "Metformin",
"category_slug": "metformin",
"category_terms": [
"metformin"
]
}
]
},
{
"title": "MS Fatigue and tDCS on Fatigue in Multiple Sclerosis",
"summary": "<b>Condition</b>: Fatigue in Multiple Sclerosis<br /><b>Interventions</b>: Procedure: Real left prefrontal tDCS - sham; Procedure: Sham - Real left prefrontal tDCS<br /><b>Sponsor</b>: Assistance Publique - Hôpitaux de Paris<br /><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05890885?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2023-06-06T16:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2023-06-06T12:50:42.940754Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "Examining a Wheelchair Exercise-training Intervention for Persons With Multiple Sclerosis",
"summary": "<b>Condition</b>: Multiple Sclerosis<br /><b>Interventions</b>: Behavioral: Seated Physical activity INtervention for persons with MS, \"SPIN\" program- Intervention Condition; Behavioral: Wellness for MS (WellMS)- Control Condition<br /><b>Sponsors</b>: University of North Texas, Denton, TX; University of Illinois at Chicago; Craig Hospital; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)<br /><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05888727?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2023-06-05T16:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2023-06-05T13:30:45.596685Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "Muscle Vibration and Fatigue in Patients With MS",
"summary": "<b>Condition</b>: Multiple Sclerosis<br /><b>Intervention</b>: Device: vibra plus<br /><b>Sponsor</b>: IRCCS Centro Neurolesi \"Bonino-Pulejo\"<br /><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05783999?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2023-03-24T12:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2023-04-07T12:40:54.269411Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
},
{
"title": "Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study",
"summary": "<b>Condition</b>: Relapsing Multiple Sclerosis<br /><b>Intervention</b>: Other: Ofatumumab<br /><b>Sponsor</b>: Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05809986?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2023-04-12T12:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2023-04-12T13:20:45.801420Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": [
{
"category_id": 39,
"category_description": "ofatumumab, Kesimpta",
"category_name": "ofatumumab",
"category_slug": "ofatumumab",
"category_terms": [
"ofatumumab",
"kesimpta"
]
}
]
},
{
"title": "Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis",
"summary": "<b>Conditions</b>: Multiple Sclerosis; Fatigue<br /><b>Interventions</b>: Device: Transcranial Magnetic Stimulation; Drug: Amantadine Hydrochloride 100 mg (milligrams) Oral Capsule<br /><b>Sponsor</b>: Hospital San Carlos, Madrid<br /><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05809414?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2023-04-12T12:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2023-04-12T13:20:45.814266Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null,
"categories": []
}
]
}